Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Apyx Medical (APYX) over the last 16 years, with Q3 2025 value amounting to $6.8 million.

  • Apyx Medical's Non-Current Assets fell 2099.73% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year decrease of 8087.2%. This contributed to the annual value of $6.7 million for FY2024, which is 570.95% down from last year.
  • Latest data reveals that Apyx Medical reported Non-Current Assets of $6.8 million as of Q3 2025, which was down 2099.73% from $6.6 million recorded in Q2 2025.
  • Apyx Medical's Non-Current Assets' 5-year high stood at $9.5 million during Q2 2023, with a 5-year trough of $4.1 million in Q1 2023.
  • Its 5-year average for Non-Current Assets is $7.9 million, with a median of $8.1 million in 2021.
  • Per our database at Business Quant, Apyx Medical's Non-Current Assets crashed by 4991.45% in 2023 and then soared by 11426.83% in 2024.
  • Apyx Medical's Non-Current Assets (Quarter) stood at $8.0 million in 2021, then increased by 10.26% to $8.8 million in 2022, then fell by 18.82% to $7.1 million in 2023, then dropped by 5.71% to $6.7 million in 2024, then rose by 0.4% to $6.8 million in 2025.
  • Its last three reported values are $6.8 million in Q3 2025, $6.6 million for Q2 2025, and $6.5 million during Q1 2025.